Etodroxizine

Source: Wikipedia, the free encyclopedia.
Etodroxizine
Clinical data
ATC code
  • None
Legal status
Legal status
Identifiers
  • 2-[2-(2-{4-[(4-Chlorophenyl)(phenyl)methyl]-1-piperazinyl}ethoxy)ethoxy]ethanol
JSmol)
  • c1ccc(cc1)C(c2ccc(cc2)Cl)N3CCN(CC3)CCOCCOCCO
  • InChI=1S/C23H31ClN2O3/c24-22-8-6-21(7-9-22)23(20-4-2-1-3-5-20)26-12-10-25(11-13-26)14-16-28-18-19-29-17-15-27/h1-9,23,27H,10-19H2
  • Key:VUFOCTSXHUWGPW-UHFFFAOYSA-N

Etodroxizine (

first-generation antihistamine of the diphenylmethylpiperazine group which is used as a sedative/hypnotic drug in Europe and South Africa.[2][3][4][5]

See also

References

  1. ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
  2. ISBN 978-3-88763-075-1
    .
  3. ISBN 978-0-8155-1856-3
    .
  4. PMID 2905131
    .
  5. PMID 2905706
    .
Retrieved from "https://en.wikipedia.org/w/index.php?title=Etodroxizine&oldid=1172715678"